Literature DB >> 12957616

Outcome of patients surviving to heart transplantation after being mechanically bridged for more than 100 days.

Christof Schmid1, Henryk Welp, Stefan Klotz, Hideo A Baba, Markus J Wilhelm, Hans H Scheld.   

Abstract

OBJECTIVE: The effect of long-term mechanical support on subsequent heart transplantation is still debated.
METHODS: We report the outcome of 41 patients (42 +/- 12 years) bridged with left ventricular assist devices (VAD; 28 Novacor, 9 HeartMate, 2 Thoratec, and 2 DeBakey) for >100 days (218 +/- 76 days) between April 1994 and March 2000). We compared follow-up with 146 patients (55 +/- 13 years) who underwent heart transplantation during the same time without prior long-term mechanical support.
RESULTS: Thirty-two of the 41 patients (78%) underwent heart transplantation, 9 patients (22%) died of multi-organ (n = 5), cardiac (n = 2), or cerebral failure (n = 2). Thirty-day post-transplant mortality includes 5 cases (3 graft failures). Within the following 2 years, another 5 patients expired, 2 of cardiac failure/sudden death. Currently, 21 of 41 patients (51%) are still alive 10 to 77 months (41 +/- 22 months) after heart transplantation (1 patient was lost for follow-up). One-year and 5-year survival rates were compared with the control group (VAD vs control, 1-year survival was 75% vs 74% and 5-year survival was 60% vs 66%). Fifteen patients are doing well in New York Heart Association Class I), and 6 are NYHA Class II despite normal left ventricular ejection fraction. Episodes of moderate acute rejection (International Society for Heart and Lung Transplantation Grade 3) occurred in 10 patients (1.3 episodes per patient), not significantly different from that of the control group (1.2 episodes per patient). Scintigraphy showed regional myocardial ischemia/transplant vasculopathy in 4 patients, and coronary angiography detected the same in 2. One patient has undergone successful retransplantation. Two patients had increased right ventricular pressure. Six patients had impaired kidney function, and 3 had impaired liver function. Seven patients experienced cytomegalovirus infection.
CONCLUSIONS: Our data indicate that patients who underwent heart transplantation after long-term mechanical support have a similar survival rate and comparable cardiac morbidity associated with acute rejection episodes.

Entities:  

Mesh:

Year:  2003        PMID: 12957616     DOI: 10.1016/s1053-2498(02)01179-8

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  6 in total

Review 1.  The use of computational fluid dynamics in the development of ventricular assist devices.

Authors:  Katharine H Fraser; M Ertan Taskin; Bartley P Griffith; Zhongjun J Wu
Journal:  Med Eng Phys       Date:  2010-11-13       Impact factor: 2.242

2.  In vivo evaluation of the HeartWare centrifugal ventricular assist device.

Authors:  Egemen Tuzun; Katy Roberts; William E Cohn; Murat Sargin; Courtney J Gemmato; Branislav Radovancevic; O H Frazier
Journal:  Tex Heart Inst J       Date:  2007

Review 3.  Management of allosensitized cardiac transplant candidates.

Authors:  Mauricio Velez; Maryl R Johnson
Journal:  Transplant Rev (Orlando)       Date:  2009-10       Impact factor: 3.943

4.  Morphological and molecular changes of the myocardium after left ventricular mechanical support.

Authors:  Hideo A Baba; Jeremias Wohlschlaeger
Journal:  Curr Cardiol Rev       Date:  2008-08

5.  Bridge to transplantation with the TandemHeart: bending the indications in a chronic aortic dissection patient with postcardiotomy shock.

Authors:  Stephane Reverdin; Igor D Gregoric; Biswajit Kar; Pranav Loyalka; Mark C Bieniarz; Scott A LeMaire; Joseph S Coselli; O H Frazier
Journal:  Tex Heart Inst J       Date:  2008

6.  Heart transplant outcomes in patients with mechanical circulatory support: cold storage versus normothermic perfusion organ preservation.

Authors:  Sandro Sponga; Giovanni Benedetti; Nunzio Davide de Manna; Veronica Ferrara; Igor Vendramin; Andrea Lechiancole; Massimo Maiani; Sandro Nalon; Chiara Nalli; Concetta Di Nora; Uberto Bortolotti; Ugolino Livi
Journal:  Interact Cardiovasc Thorac Surg       Date:  2021-04-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.